147 related articles for article (PubMed ID: 9315050)
1. Effect of mass treatments with ivermectin, with only partial compliance, on prevalence and intensity of O. volvulus infection in adults and in untreated 4 and 5 year-old children in Burundi.
Newell ED
Trop Med Int Health; 1997 Sep; 2(9):912-6. PubMed ID: 9315050
[TBL] [Abstract][Full Text] [Related]
2. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
[TBL] [Abstract][Full Text] [Related]
3. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
4. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
[TBL] [Abstract][Full Text] [Related]
5. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
6. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
7. Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.
Koroma JB; Sesay S; Conteh A; Koudou B; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y; Bockarie MJ
Infect Dis Poverty; 2018 Apr; 7(1):30. PubMed ID: 29628019
[TBL] [Abstract][Full Text] [Related]
8. Treatment of onchocerciasis with ivermectin (Province of Bururi, Burundi): parasitologic and clinical evaluation of different periodicities of treatment.
Vyungimana F; Newell E
Am J Trop Med Hyg; 1998 Nov; 59(5):828-31. PubMed ID: 9840606
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
Senyonjo L; Oye J; Bakajika D; Biholong B; Tekle A; Boakye D; Schmidt E; Elhassan E
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004905. PubMed ID: 27529622
[TBL] [Abstract][Full Text] [Related]
10. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
Cupp EW; Cupp MS
Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
[TBL] [Abstract][Full Text] [Related]
11. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.
Katabarwa MN; Eyamba A; Nwane P; Enyong P; Yaya S; Baldiagaï J; Madi TK; Yougouda A; Andze GO; Richards FO
Am J Trop Med Hyg; 2011 Dec; 85(6):1041-9. PubMed ID: 22144441
[TBL] [Abstract][Full Text] [Related]
12. Combined benefits of annual mass treatment with ivermectin and cattle zooprophylaxis on the severity of human onchocerciasis in northern Cameroon.
Seidenfaden R; Fischer A; Bonow I; Ekale D; Tanya V; Renz A
Trop Med Int Health; 2001 Sep; 6(9):715-25. PubMed ID: 11555439
[TBL] [Abstract][Full Text] [Related]
13. Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan.
Rodríguez-Pérez MA; Lutzow-Steiner MA; Segura-Cabrera A; Lizarazo-Ortega C; Domínguez-Vázquez A; Sauerbrey M; Richards F; Unnasch TR; Hassan HK; Hernández-Hernández R
Am J Trop Med Hyg; 2008 Aug; 79(2):239-44. PubMed ID: 18689630
[TBL] [Abstract][Full Text] [Related]
14. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
[TBL] [Abstract][Full Text] [Related]
15. Integrated control of Onchocerca volvulus infection in a hyperendemic zone in Sierra Leone.
Gbakima AA
East Afr Med J; 1996 Mar; 73(3):159-63. PubMed ID: 8698012
[TBL] [Abstract][Full Text] [Related]
16. Ivermectin in onchocerciasis control in the forest zone of Cote d'Ivoire.
Soungalo T; Soumana D; Moussa S; François R
Acta Trop; 1997 Dec; 68(3):297-300. PubMed ID: 9492914
[TBL] [Abstract][Full Text] [Related]
17. The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
Nikièma AS; Koala L; Sondo AK; Post RJ; Paré AB; Kafando CM; Kambiré RS; Sow B; Bougouma C; Dabiré RK; Traoré S
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009117. PubMed ID: 33647010
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
Osei-Atweneboana MY; Eng JK; Boakye DA; Gyapong JO; Prichard RK
Lancet; 2007 Jun; 369(9578):2021-2029. PubMed ID: 17574093
[TBL] [Abstract][Full Text] [Related]
19. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
[TBL] [Abstract][Full Text] [Related]
20. Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments.
Boussinesq M; Prod'hon J; Chippaux JP
Trans R Soc Trop Med Hyg; 1997; 91(1):82-6. PubMed ID: 9093638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
